Wolfgang Miesbach: Therapeutic Potential of Protein S Inhibition in Glanzmann Thrombasthenia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Rim Diab et al, published in ASH, adding:
“Honored to have attended last weekend’s EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, where Rim Diab from the Anne Angelillo-Scherrer group presented her inspiring work on ‘Enhancing Hemostasis in Glanzmann Thrombasthenia via Protein S Inhibition.’
I particularly appreciated how she concluded by reminding us that Glanzmann himself was a Swiss pediatrician who first described this rare platelet disorder in 1918 during his tenure at the Children’s Hospital in Bern, Switzerland — beautifully linking the roots of the disease to today’s one of the most exciting haemostasis research.”
Title: Enhancing hemostasis in glanzmann thrombasthenia via protein S inhibition
Authors: Rim Diab, Tanja Knopp, Mathieu Fiore, Sonia Avoue-celerier, Léonard Julien Simon Schacher, Raja Prince-Eladnani, Anne Angelillo-Scherrer
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention